Physician profile
John Erik Beresh
NPI 1700845344
$11,541.60
in general payments reported to CMS, 2019-2025
37 companies · $1,386 in 2025
The $1,386 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $905 · 2020: $2,105 · 2021: $1,935 · 2022: $1,694 · 2023: $1,901 · 2024: $1,616 · 2025: $1,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,902.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $3,047.26 | 2020-2024 | Mild Device Kit |
| Abbott Laboratories | $1,281.47 | 2019-2024 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,207.79 | 2019-2025 | Relistor |
| Medtronic, INC. | $992.54 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Nevro Corp. | $545.73 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $499.19 | 2020-2025 | Belbuca, Xtampza |
| Abbvie INC. | $427.40 | 2022-2025 | Ubrelvy, Qulipta |
| Pfizer INC. | $396.43 | 2019-2025 | |
| Boston Scientific Corporation | $374.96 | 2019-2025 | Clinical Trial Product |
| Biotronik Nro, INC. | $369.35 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $344.52 | 2024-2025 | Evoke |
| Grt US Holding, INC. | $203.04 | 2020-2022 | |
| Stryker Corporation | $193.60 | 2024 | Mild Device Kit |
| Amgen INC. | $176.25 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $153.16 | 2019-2021 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Beresh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.